arrow
Back
J

Jingtong Xu

The First Affiliated Hospital of Nanjing Medical University

7H-index
21Paper Count
215Citation Count
Published Papers 11
Publication Date
Correction to “Enrichment and Detection of HER2-Expressing Extracellular Vesicles Based on DNA Tetrahedral Nanostructures: A New Strategy for Liquid Biopsy in Breast Cancer”
err2026-02-13
err0
PREAI
errFeng Xu; Ke Wang; Chi Xu; Jingtong Xu; Chengjun Zhu; Ye Zhu; Chuandong Zhu; Wenwen Zhang; Jian Zhang; Zhe Li; Xiaoxiang Guan
errShare
errSave
Clinicopathological and molecular correlates of clinical benefit from disitamab vedotin (RC48), a HER-2-targeting antibody-drug conjugate, in metastatic urothelial carcinoma: a multi-center, real-world study
err2025-10-03
err0
errOAAI
errZhaopei Liu; Kaifeng Jin; Ziyue Xu; Han Zeng; Xiaohe Su; Jingtong Xu; Yawei Ding; Hailong Liu; Yu Zhu; Le Xu; Jiejie Xu; Zewei Wang; Yuan Chang
errShare
errSave
Exosomal mRNA in plasma serves as a predictive marker for microvascular invasion in hepatocellular carcinoma
err2024-07-07
err0
PREAI
errXin, Zhaodan; Chen, Hao; Xu, Jingtong; Zhang, Haili; Peng, Yufu; Ren, Jing; Guo, Qin; Song, Jiajia; Jiao, Lin; You, Liting; Bai, Ling; Wei, Yonggang; Zhou, Juan; Ying, Binwu
errShare
errSave
Precise nano-system-based drug delivery and synergistic therapy against androgen receptorpositive triple-negative breast cancer
err2024-06-01
err5
errOAAI
errGao, Fangyan; Wu, Yueyao; Wang, Runtian; Yao, Yuhui; Liu, Yiqiu; Fan, Lingling; Xu, Jingtong; Zhang, Jian; Han, Xin; Guan, Xiaoxiang
errShare
errSave
RAD51 Expression as a Biomarker to Predict Efficacy of Platinum-Based Chemotherapy and PD-L1 Blockade for Muscle-Invasive Bladder Cancer
err2024-05-27
err0
PREAI
errLi, Bingyu; Jin, Kaifeng; Liu, Zhaopei; Su, Xiaohe; Xu, Ziyue; Liu, Ge; Xu, Jingtong; Chang, Yuan; Wang, Yiwei; Zhu, Yu; Xu, Le; Wang, Zewei; Liu, Hailong; Zhang, Weijuan
errShare
errSave
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma
err2024-02-21
err2
errOAAI
errJin, Kaifeng; Xu, Jingtong; Su, Xiaohe; Xu, Ziyue; Li, Bingyu; Liu, Ge; Liu, Hailong; Wang, Yiwei; Zhu, Yu; Xu, Le; Zhang, Weijuan; Liu, Zhaopei; Wang, Zewei; Chang, Yuan; Xu, Jiejie
errShare
errSave
Cell-cell communication characteristics in breast cancer metastasis
err2024-01-19
err5
errOAAI
errXu, Jingtong; Gao, Fangyan; Liu, Weici; Guan, Xiaoxiang
errShare
errSave
errShare
errSave
Untangling the web of intratumor microbiota in lung cancer
err2023-11-01
err3
errOAAI
errLiu, Weici; Xu, Jingtong; Pi, Zheshun; Chen, Yundi; Jiang, Guanyu; Wan, Yuan; Mao, Wenjun
errShare
errSave
APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
err2022-05-01
err12
errOAAI
errChen, Jiajin; Shen, Sipeng; Li, Yi; Fan, Juanjuan; Xiong, Shiyu; Xu, Jingtong; Zhu, Chenxu; Lin, Lijuan; Dong, Xuesi; Duan, Weiwei; Zhao, Yang; Qian, Xu; Liu, Zhonghua; Wei, Yongyue; Christiani, David C.; Zhang, Ruyang; Chen, Feng
errShare
errSave
Novel Aptamer-Drug Conjugate for Targeted Therapy in Triple-Negative Breast Cancer
err
err0
PREAI
errFeng Xu; Jingtong Xu; Feng Han; Ke Wang; Fulong Wang; Hanyang Yu; Xiaoxiang Guan
errShare
errSave